Back to Newsroom

Invenra Enters Collaboration Agreement with Merck to Identify Therapeutic Antibodies Against Challenging Target

MADISON, WI – July 18, 2017 – Invenra today announced a collaboration with Merck, known as MSD outside the United States and Canada, to discover fully human therapeutic antibodies against an unnamed target of interest to Merck.  Financial details of the deal were not disclosed.